Michael Hengartner
InvestorPresident of the ETH Board and Chairman of the Executive Committee of the ETH Domain at Novartis Venture Fund
About
Michael Hengartner, PhD, MBA, is President of the ETH Board and Chairman of the Executive Committee of the ETH Domain. He previously served as Rector of the University of Zurich (2014-2020) and President of swissuniversities (2016-2020). He studied biochemistry at the Université Laval, earned his PhD at MIT in 1994, led a research group at Cold Spring Harbor Laboratory, and later held a professorship at the University of Zurich, focusing his research on the molecular basis of apoptosis.
Colleagues at Novartis Venture Fund
Aaron Nelson
Managing Director at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Frequently asked questions
- Who is Michael Hengartner?
- Michael Hengartner, PhD, MBA, is President of the ETH Board and Chairman of the Executive Committee of the ETH Domain. He previously served as Rector of the University of Zurich (2014-2020) and President of swissuniversities (2016-2020). He studied biochemistry at the Université Laval, earned his PhD at MIT in 1994, led a research group at Cold Spring Harbor Laboratory, and later held a professorship at the University of Zurich, focusing his research on the molecular basis of apoptosis.
- Where does Michael Hengartner work?
- Michael Hengartner is President of the ETH Board and Chairman of the Executive Committee of the ETH Domain at Novartis Venture Fund.